Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma-Reference-Cited by-同舟云学术

Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma

Published:2010-02-16 Issue:7 Volume:12 Page:720-724
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro-Oncology

Author:

Pels H.,Juergens A.,Schirgens I.,Glasmacher A.,Schulz H.,Engert A.,Schackert G.,Reichmann H.,Kroschinsky F.,Vogt-Schaden M.,Egerer G.,Bode U.,Deckert M.,Fimmers R.,Urbach H.,Schmidt-Wolf I. G. H.,Schlegel U.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/12/7/720/4204558/noq010.pdf

Reference19 articles.

1. Treatment for Primary CNS Lymphoma: The Next Step

2. Primary central nervous system lymphoma: age and performance status are more important than treatment modality

3. Primary central nervous system lymphoma: A review

4. Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020;Neuro-Oncology;2024-06-25

2. Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers;Acta Oncologica;2023-06-03

3. Cytoreductive Surgery for Primary Central Nervous System Lymphoma: Is it time to consider extent of resection?;Journal of Clinical Neuroscience;2022-12

4. Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma;Leukemia & Lymphoma;2022-05-02

5. Parameters of MR perfusion-weighted imaging predict the response and prognosis to high-dose methotrexate-based chemotherapy in immunocompetent patients with primary central nervous system lymphoma;Journal of Clinical Neuroscience;2022-01